Literature DB >> 2381895

Effect of ivermectin on filariae of Mastomys natalensis.

U R Rao1, R Chandrashekar, D Subrahmanyam.   

Abstract

The efficacy of ivermectin (Iv) was evaluated against four species of filariae, Litomosoides carinii, Acanthocheilonema viteae, Brugia pahangi and Brugia malayi in Mastomys natalensis. Animals with patent infections, induced with L3 larvae, by intravenous (iv) infusion of the respective microfilariae (Mf) (5 x 10(4) Mf per animal) or by intraperitoneal (ip) route (2 x 10(4) Mf per animal) were used in this study. A single dose of Iv (100 micrograms.kg-1) given subcutaneously (sc) to Mastomys infected with L. carinii or A. viteae resulted in the disappearance of microfilaremia within 2 h of treatment. Iv treatment of sc-infected animals with Brugia spp. had no immediate effect on the circulating Mf 60 days post-treatment. In contrast, such treatment of animals infected with Mf by intravenous infusion completely eliminated the larvae of all four species from the circulation. Iv treatment had no significant effect on the Mf of L. carinii, B. pahangi and B. malayi in animals infected by the ip route. However, the drug had dramatic effect in killing the Mf of A. viteae in the peritoneal cavity. Sera from Iv-treated normal or from L. carinii- or A. viteae-infected Mastomys were effective in clearing the circulating Mf of the species when administered to animals with the respective infections. Similar rapid clearance of Mf was seen when the sera were administered to animals infected iv with these larvae. Furthermore, adult females of L. carinii and A. viteae recovered from Mastomys on different days after Iv treatment released smaller numbers of Mf in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2381895     DOI: 10.1007/bf00931058

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  13 in total

1.  Pharmacology of ivermectin.

Authors:  J L Bennett; J F Williams; V Dave
Journal:  Parasitol Today       Date:  1988-08

2.  Effect of ivermectin in Dipetalonema viteae and Litomosoides carinii infections of Mastomys natalensis.

Authors:  H Zahner; I Sänger; G Lämmler; H A Müller
Journal:  Trop Med Parasitol       Date:  1987-06

3.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

4.  Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti.

Authors:  S Diallo; M A Aziz; O Ndir; S Badiane; I B Bah; O Gaye
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

5.  Separation of viable microfilariae free of blood cells on Percoll gradients.

Authors:  R Chandrashekar; U R Rao; G R Rajasekariah; D Subrahmanyam
Journal:  J Helminthol       Date:  1984-03       Impact factor: 2.170

6.  Filarial infections of Mastomys natalensis and their relevance for experimental chemotherapy.

Authors:  I Sänger; G Lämmler; P Kimmig
Journal:  Acta Trop       Date:  1981-09       Impact factor: 3.112

7.  The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.

Authors:  K Awadzi; K Y Dadzie; H Schulz-Key; H M Gilles; A J Fulford; M A Aziz
Journal:  Ann Trop Med Parasitol       Date:  1986-08

8.  The microfilaricidal activity of ivermectin in vitro and in vivo.

Authors:  E Devaney; R E Howells
Journal:  Tropenmed Parasitol       Date:  1984-03

9.  Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees.

Authors:  H R Taylor; M Trpis; E W Cupp; B Brotman; H S Newland; P T Soboslay; B M Greene
Journal:  Am J Trop Med Hyg       Date:  1988-07       Impact factor: 2.345

10.  Effect of ivermectin against subperiodic Brugia malayi infection in the leaf monkey, Presbytis cristata.

Authors:  J W Mak; P L Lam; A N Rain; K Suresh
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

View more
  2 in total

1.  Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra Bhattacharya; F J Ahmad; Mohammad Samim; M Z Abidin; A K Dinda
Journal:  Parasitol Res       Date:  2013-12-24       Impact factor: 2.289

Review 2.  Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model.

Authors:  Frederic Risch; Manuel Ritter; Achim Hoerauf; Marc P Hübner
Journal:  Parasitol Res       Date:  2021-02-06       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.